TMO logo

THERMO FISHER SCIENTIFIC INC

TMONYSE
πŸ† #59 by market capUS Equity
$296.88β–² $9.86 (+3.32%)
Simulated price
πŸ””
Track TMO
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 3.3%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$249.58B
Large Cap
πŸ“ˆRevenue Growth (YoY)
+3.9%
Slowing
πŸ“ŠGross Margin
41.0%
Healthy
πŸ’΅FCF Margin
15.8%
Healthy
βš–οΈP/S Ratio
5.4x
Fair
Otter Score
72
Fair
No chart data available for TMO.

Trading Snapshot

Day Range
$295.15 – $301.61
52-Week Range
$435.27 – $682.98
Volume
$7.01B
Avg Volume
$7.07B
Shares Outstanding
369.7M
Next Earnings
Oct 23, 2026

Fundamentals Snapshot

Annual Revenue
$44.56B
Last Q Revenue
$11.99B
P/E Ratio
36.3
P/S Ratio
5.4x
EPS (TTM)
$18.81
Dividend Yield
0.27%
Dilution (1yr)
βˆ’1.6%

Why Investors Own TMO

  • βœ“High-growth profile β€” revenue up +44.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 58% gross margin and 13% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

TMO logo

THERMO FISHER SCIENTIFIC INC

TMO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$44.6Bβ–² +3.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
40.9%β–Ό βˆ’1.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$8.1Bβ–² +5.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$6.3Bβ–Ό βˆ’13.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
377.0Mβ–Ό βˆ’1.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$29.5Bβ–Ό βˆ’$767M YoY
StockOtter Β· stockotter.space

About THERMO FISHER SCIENTIFIC INC

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
72/100

Analyst Price Target

β“˜
Average Target
$368.54
β–² +24.1% Upside
High Target$413.08
Low Target$333.31
Based on 35 analysts

Latest News & Updates